Kubota Kiyoshi, Koide Daisuke, Hirai Toshiki
Department of Pharmacoepidemiology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):387-94. doi: 10.1002/pds.964.
Five data mining methodologies for detecting a possible signal from spontaneous reports on adverse drug reactions (ADRs) were compared.
The five methodologies, the Bayesian method using the Gamma Poissson Shrinker (GPS), the method employed in the UK Medicines Control Agency (MCA), the Bayesian Confidence Propagation Neural Network (BCPNN), the method using the 95% confidence interval (CI) for the reporting odds ratio (RORCI) and that using the 95% CI of the proportional reporting ratio (PRRCI) were compared using Japanese data obtained between 1998 and 2000.
There were all in all 38,731 drug-ADR combinations. The count of drug-ADR pairs was equal to 1 or 2 for 31,230 combinations and none of them were identified as a possible signal with the MCA or BCPNN. Similarly, the GPS detected a possible signal in none of the combinations where the count was equal to 1 but in 7.5% of the combinations where the count was equal to 2. The RORCI and PRRCI detected a possible signal in more than half of the combinations where the count was equal to 1 or 2. When the pairwise agreement on whether or not a drug-ADR combination satisfied the criteria for a possible signal was assessed for the 38,731 combinations, the concordance measure kappa was greater than 0.9 between the MCA and BCPNN and between the RORCI and PRRCI. Kappa was around 0.6 between the GPS and MCA and between the GPS and BCPNN. Otherwise, kappa was smaller than 0.2.
The drug-ADR combinations detected as a possible signal vary between different methodologies.
比较五种用于从药品不良反应(ADR)自发报告中检测可能信号的数据挖掘方法。
使用1998年至2000年期间获取的日本数据,对五种方法进行比较,这五种方法分别是使用伽马泊松收缩器(GPS)的贝叶斯方法、英国药品控制局(MCA)采用的方法、贝叶斯置信传播神经网络(BCPNN)、使用报告比值比(RORCI)的95%置信区间(CI)的方法以及使用比例报告比值(PRRCI)的95% CI的方法。
总共有38,731种药物 - ADR组合。对于31,230种组合,药物 - ADR对的计数等于1或2,并且这些组合中没有一个被MCA或BCPNN识别为可能的信号。同样,GPS在计数等于1的组合中未检测到可能的信号,但在计数等于2的组合中有7.5%检测到了可能的信号。RORCI和PRRCI在计数等于1或2的组合中,超过一半检测到了可能的信号。当对38,731种组合评估药物 - ADR组合是否符合可能信号的标准的成对一致性时,MCA与BCPNN之间以及RORCI与PRRCI之间的一致性度量kappa大于0.9。GPS与MCA之间以及GPS与BCPNN之间的kappa约为0.6。否则,kappa小于0.2。
不同方法检测为可能信号的药物 - ADR组合有所不同。